🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pegylated-asparaginase (PEG-ASP) is an important part of the treatment of c...
Status
Completed
Location
Aahus University hospial, hematological department
Start Date
2017-08-23
Trial ID
NCT03267030
Treatments Being Tested
The protocol aims at adding GRASPA (L-asparaginase encapsulated in red bloo...
Status
Completed
Location
Hôpital l'Archet 1
Start Date
2013-02
Trial ID
NCT01810705
Treatments Being Tested
Primary objective : * To explore the relation between 3 doses of GRASPA an...
Status
Completed
Location
Hopital Debrousse
Start Date
2006-01
Trial ID
NCT00723346
Treatments Being Tested
The main purpose of this study is to determine the maximum tolerated and ef...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT01523782
Treatments Being Tested
Early Access Program to provide L-asparaginase encapsulated in Erythrocyte ...
Status
No Longer Available
Location
Hôpital Jean Minjoz - Batiment MEMCP
Start Date
TBD
Trial ID
NCT02197650
Treatments Being Tested
The interest in using L-asparaginase in pancreatic cancer arose from in vit...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT01523808
Treatments Being Tested
This is an open-label, multicenter, randomized, Phase 2/3 study in patients...
Status
Terminated
Location
ZNA Middelheim
Start Date
2019-06-13
Trial ID
NCT03674242
Treatments Being Tested
Asparaginase is a cornerstone in the treatment of ALL, but its utility is l...
Status
Completed
Location
Hopital Des Enfants Reine Fabiola
Start Date
2009-12
Trial ID
NCT01518517
Treatments Being Tested